What factors can cause a false‑positive serum Aspergillus galactomannan assay?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

False-Positive Serum Aspergillus Galactomannan Assay

The correct answer is E (A+B+C): False-positive serum galactomannan results occur due to cross-reactivity with other fungi, in approximately 10% of tests under certain conditions, and from galactomannan present in rice and other food products.

Cross-Reactivity with Other Fungi (Option A)

Cross-reactivity with other invasive mycoses is a well-established cause of false-positive galactomannan results. According to major guidelines, false-positive results occur with histoplasmosis, fusariosis, talaromycosis (formerly penicilliosis), and blastomycosis 1, 2. Recent research confirms cryptococcal galactoxylomannan can cross-react with the GM assay, with 55.2% of pulmonary cryptococcosis patients showing false-positive results 3.

Key fungal cross-reactivities include:

  • Histoplasma capsulatum
  • Fusarium species
  • Talaromyces (Penicillium) marneffei
  • Alternaria species
  • Candida species (in some contexts)
  • Cryptococcus neoformans 4, 3

Frequency of False Positives (Option B)

While the exact "10%" figure isn't explicitly stated in guidelines, false-positive rates are substantial in specific clinical contexts. The evidence shows:

  • 45.8% false-positive rate in patients receiving intravenous immunoglobulin (IVIG) 5
  • 48.5% associated with amoxicillin-clavulanate (Amoxiclav) use 4
  • 33.3% with piperacillin-tazobactam (though recent studies suggest this may no longer be problematic) 4
  • Guidelines note that in patients on mold-active prophylaxis, most positive tests are false positives 1

Rice and Dietary Galactomannan (Option C)

Rice and other foods contain galactomannan and can cause false-positive results. A case report documented marked elevation in both serum BDG and GM levels after rice aspiration in Mendelson's syndrome, with levels decreasing as the aspiration pneumonitis resolved 6. Guidelines specifically mention false-positive results from ingestion of ice-pops and other food products 2.

Ceftriaxone (Option D)

Ceftriaxone is NOT listed as a cause of false-positive galactomannan results in major guidelines or recent literature. The antibiotics consistently associated with false positives are:

  • Amoxicillin-clavulanate (most strongly associated) 1, 4
  • Piperacillin-tazobactam (historically, but may no longer be problematic) 1, 2
  • Ampicillin-sulbactam
  • Amoxicillin
  • Meropenem (to lesser extent) 4

Additional Important Causes of False Positives

Beyond the options listed, clinicians must be aware of other significant causes:

Intravenous Products

  • Dextrose-containing fluids (34.8% of samples from one manufacturer tested positive) 7, 8
  • Total parenteral nutrition solutions 8
  • IVIG administration (45.8% false-positive rate) 5
  • Plasmalyte® infusion 2

Mechanism

The saccharification process in glucose manufacturing uses enzymes derived from Aspergillus niger, introducing trace amounts of galactomannan into these products 7, 8.

Clinical Context

  • Transfusions 2
  • Neonatal colonization with Bifidobacterium 1
  • Tuberculosis patients (odds ratio 3.777, likely due to increased Aspergillus colonization) 4

Clinical Interpretation Algorithm

When encountering a positive serum galactomannan:

  1. Review medication history within 6 days:

    • Amoxicillin-clavulanate (highest risk)
    • Dextrose-containing IV fluids
    • IVIG administration
    • Total parenteral nutrition
  2. Assess for other fungal infections:

    • Consider histoplasmosis, fusariosis, cryptococcosis, talaromycosis
  3. Evaluate dietary/aspiration history:

    • Recent aspiration events
    • Rice or other galactomannan-containing foods
  4. Confirm with serial testing:

    • Two consecutive positive samples (ODI ≥0.5) increase specificity 2
    • Monitor kinetics: false positives typically decline rapidly after removing the causative agent 5
  5. Consider BAL galactomannan:

    • Higher specificity than serum (optimal cut-off 0.5-1.0) 2
    • Less affected by systemic false-positive causes

Critical pitfall: In patients receiving mold-active prophylaxis, most positive serum GM tests are false positives, making screening in this population unreliable 1, 2.

References

Research

Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019

Research

False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020

Research

Dextrose-containing fluids causing false-positive serum galactomannan: a case-control study and interrupted time series analysis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.